Data / Drug companies / Atenolol
Atenolol: 36 companies and 129 products in the FDA NDC directory
Atenolol is listed in the FDA National Drug Code Directory by 36 companies, with 129 products in commercial distribution. 126 of the products (97.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on August 25, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 36
- Products
- 129
- Generic (ANDA) products
- 126 (97.7%)
- Application numbers
- 9
- Routes
- Oral
- Brand names
- Tenormin
- openFDA record search
- api.fda.gov
Companies that list atenolol
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 14 | tablet | Generic drugs (ANDA) | November 21, 2019 |
| Bryant Ranch Prepack | 10 | tablet | Generic drugs (ANDA) | November 21, 2019 |
| NuCare Pharmaceuticals,Inc. | 9 | tablet | Generic drugs (ANDA) | November 21, 2019 |
| Preferred Pharmaceuticals Inc. | 7 | tablet | Generic drugs (ANDA) | April 22, 2026 |
| Northwind Health Company, LLC | 6 | tablet | Generic drugs (ANDA) | December 28, 2022 |
| Direct_Rx | 4 | tablet | Generic drugs (ANDA) | November 22, 2022 |
| Remedyrepack Inc. | 4 | tablet | Generic drugs (ANDA) | February 12, 2025 |
| St. Mary's Medical Park Pharmacy | 4 | tablet | Generic drugs (ANDA) | August 25, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | 3 | tablet | Generic drugs (ANDA) | November 16, 2004 |
| Asclemed USA Inc. | 3 | tablet | Generic drugs (ANDA) | November 21, 2019 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | October 31, 2007 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | December 19, 2022 |
| Cardinal Health 107, LLC | 3 | tablet | Generic drugs (ANDA) | July 20, 2026 |
| Coupler LLC | 3 | tablet | Generic drugs (ANDA) | May 6, 2026 |
| Golden State Medical Supply, Inc. | 3 | tablet | Generic drugs (ANDA) | April 26, 1999 |
| Ipca Laboratories Limited | 3 | tablet | Generic drugs (ANDA) | December 4, 2007 |
| Mylan Institutional Inc. | 3 | tablet | Generic drugs (ANDA) | June 16, 1999 |
| Mylan Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | June 17, 1999 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | October 8, 2005 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | June 10, 2010 |
| QPharma, Inc. | 3 | tablet | Generic drugs (ANDA) | June 10, 2010 |
| Rising Pharma Holdings, Inc. | 3 | tablet | Generic drugs (ANDA) | June 10, 2010 |
| Safecor Health, LLC | 3 | tablet | Generic drugs (ANDA) | February 3, 2026 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet | Generic drugs (ANDA) | November 16, 2004 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet | Generic drugs (ANDA) | November 21, 2019 |
| Upsher-Smith Laboratories, LLC | 3 | tablet | New drug applications (NDA) | August 1, 2024 |
| Zydus Lifesciences Limited | 3 | tablet | Generic drugs (ANDA) | October 8, 2005 |
| Zydus Pharmaceuticals USA Inc. | 3 | tablet | Generic drugs (ANDA) | October 8, 2005 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | February 20, 2014 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 2 | tablet | Generic drugs (ANDA) | June 10, 2010 |
| Proficient Rx LP | 2 | tablet | Generic drugs (ANDA) | November 16, 2004 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | October 25, 2021 |
| Major Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | October 31, 2007 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | October 8, 2005 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | October 8, 2005 |
| Quality Care Products, LLC | 1 | tablet | Generic drugs (ANDA) | January 25, 2024 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 129 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 126 | 97.7% |
| New drug applications (NDA) | 3 | 2.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| beta-Adrenergic Blocker | 129 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.